Concepedia

Author

Beate Wieseler

Institute for Quality and Efficiency in Health CareORCID

Also Known As

B Wieseler, B. Wieseler, Beate Wieseler

64

Publications

2.6K

Citations

21

H-Index

75

Concepts

All Affiliations

Institute for Quality and Efficiency in Health CareUniversity of FreiburgBelgian Health Care Knowledge Centre (KCE)
BW

About

Beate Wieseler is an author at Institute for Quality and Efficiency in Health Care specializing in medicine, health policy, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

8

8

391

2

Public Health

4

4

267

3

Engineering

2

2

57

4

Health Sciences

2

2

67

5

Natural Sciences

1

1

18

Beate Wieseler

×

19

Publications

921

Citations

16

H-Index

YearCitations

Completeness of Reporting of Patient-Relevant Clinical Trial Outcomes: Comparison of Unpublished Clinical Study Reports with Publicly Available Data

Beate Wieseler, Natalia Wolfram, Natalie McGauran,

PLoS Medicine

2013

129

New drugs: where did we go wrong and what can we do better?

Beate Wieseler, Natalie McGauran, Thomas Kaiser

BMJ

2019

123

Impact of document type on reporting quality of clinical drug trials: a comparison of registry reports, clinical study reports, and journal publications

Beate Wieseler, M Kerekeş, V. Vervoelgyi,

BMJ

2012

107

Pathways to independence: towards producing and using trustworthy evidence

Ray Moynihan, Lisa Bero, Sue Hill,

BMJ

2019

105

Complications, co-morbidity, and blood glucose control in type 2 diabetes mellitus patients in Germany - results from the CODE-2<sup>TM</sup> study

A Liebl, A Neiss, A Spannheimer,

Experimental and Clinical Endocrinology & Diabetes

2002

90

Requirements for the Translocation of Elongation-arrested, Ribosome-associated OmpA across the Plasma Membrane ofEscherichia coli

M Behrmann, Hans‐Georg Koch, Thomas Hengelage,

Journal of Biological Chemistry

1998

50

Information on new drugs at market entry: retrospective analysis of health technology assessment reports versus regulatory reports, journal publications, and registry reports

Michael Köhler, S. Haag, K. Biester,

BMJ

2015

42

Replacing RCTs with real world data for regulatory decision making: a self-fulfilling prophecy?

Beate Wieseler, Mattias Neyt, Thomas Kaiser,

BMJ

2023

39

Early benefit assessment of new drugs in Germany – Results from 2011 to 2012

Helmut Hörn, Katrin Nink, Natalie McGauran,

Health Policy

2014

37

Finding studies on reboxetine: a tale of hide and seek

Beate Wieseler, Natalie McGauran, Thomas Kaiser

BMJ

2010

36

Page 1